Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer
.
Show all posts
Showing posts with label
First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer
.
Show all posts
Monday, December 4, 2017
FDA Approves Alecensa (alectinib) as First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer
›
Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Appl...
›
Home
View web version